ST. LOUIS--(BUSINESS WIRE)--Jan. 11, 2006--Tripos, Inc. (Nasdaq:TRPS), a leading provider of drug discovery chemistry and informatics products and services, today announced that Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), has chosen Tripos discovery informatics technology as the basis for its next-generation discovery IT solution to be used by scientists throughout Wyeth’s worldwide discovery operations. Under the terms of this agreement, Tripos is expected to receive approximately $5 million in software license and professional services fees over the next 12-18 months, with certain payments contingent upon the successful achievement of project milestones.
